Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer

This study has been completed.
Information provided by (Responsible Party):
Bayer Identifier:
First received: August 5, 2011
Last updated: July 3, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2015
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)